Standing Committee on Health (Canada)

Standing Committee on Health (Canada)
Name	Standing Committee on Health
Type	Standing committee
Chamber	House of Commons
Jurisdiction	Parliament of Canada

Standing Committee on Health (Canada) is a permanent legislative committee of the House of Commons of Canada responsible for scrutinizing federal matters relating to public health, health care delivery, biotechnology, pharmaceuticals and health research. The committee examines legislation, conducts studies, and reports to the House of Commons of Canada while engaging stakeholders such as provincial ministries, territorial departments, health agencies and academic institutions. Its work intersects with federal bodies, international organizations and non-governmental agencies that shape Canadian health policy.

Mandate and Jurisdiction

The committee's mandate originates from the standing orders of the House of Commons of Canada and covers topics assigned by the House and by statute, including oversight of the Health Canada portfolio, the Public Health Agency of Canada, the Canadian Institutes of Health Research, and federal initiatives under the Canada Health Act. It studies legislation such as bills introduced to amend the Food and Drugs Act, the Controlled Drugs and Substances Act, and statutes affecting the Patented Medicine Prices Review Board and the Canadian Food Inspection Agency. The committee reviews federal spending estimates related to the Minister of Health (Canada), examines appointments to agencies like the Canadian Blood Services board, and evaluates intergovernmental accords that involve the Council of the Federation and the Council of the Federation#Health ministers.

Membership and Leadership

Membership is drawn from MPs across political parties represented in the House of Commons of Canada, with proportional representation reflecting party standings such as the Liberal Party of Canada, the Conservative Party of Canada, the New Democratic Party, the Bloc Québécois, and other recognized parties. The committee elects a chair and vice-chairs; chairs have included MPs who later served in portfolios like the Minister of Health (Canada), ministers in provincial cabinets such as the Premier of Ontario or the Premier of Quebec, and members active in caucuses like the Parliamentary Health Caucus. Members often include legislators with backgrounds at institutions such as McGill University Faculty of Medicine, the University of Toronto Faculty of Medicine, and health-focused NGOs like the Canadian Cancer Society or the Heart and Stroke Foundation of Canada.

Activities and Procedures

The committee conducts public hearings, in camera meetings, evidence-gathering sessions and site visits to facilities including regional hospitals administered by provincial health ministries like the Alberta Health Services and the British Columbia Ministry of Health. It summons witnesses from organizations such as the World Health Organization, the Pan American Health Organization, the Canadian Medical Association, the Royal College of Physicians and Surgeons of Canada, biotech firms, and patient advocacy groups like Alzheimer Society of Canada. Procedural rules derive from the Standing Orders of the House of Commons, with support from the Parliamentary Budget Officer and procedural clerks from the House of Commons of Canada. The committee prepares reports, motions for debate, and conducts clause-by-clause study during bill review, interacting with the Senate of Canada when legislation proceeds to the upper chamber.

Major Studies and Reports

The committee has produced influential reports on topics such as the federal response to pandemics, involving assessments of the Public Health Agency of Canada and the federal-provincial framework following outbreaks like the 2003 SARS outbreak and the COVID-19 pandemic in Canada. It has examined the regulation of novel therapies under the Food and Drugs Act and oversight of substances regulated under the Controlled Drugs and Substances Act, including opioids and cannabis legalized under the Cannabis Act. Studies have addressed long-term care reform after incidents in provincial long-term care homes highlighted in inquiries such as the Ontario Long-Term Care COVID-19 Commission, as well as pharmacare policy proposals connected to advocacy by the Canadian Pharmacists Association and the Canadian Medical Association. Reports often recommend legislative amendments, funding allocations, or new oversight mechanisms involving bodies like the Patented Medicine Prices Review Board and the Canadian Institutes of Health Research.

Legislative and Policy Influence

Through reports, witness testimony and clause-by-clause review, the committee influences legislation including amendments to bills introduced by the Minister of Health (Canada), private members’ bills from MPs such as those from the New Democratic Party or the Conservative Party of Canada, and budgetary allocations in federal estimates presented by the Minister of Finance (Canada). Recommendations have informed federal negotiations with provinces through forums like the Council of the Federation and contributed to interjurisdictional frameworks involving the First Nations Health Authority and territorial health departments such as the Yukon Department of Health and Social Services. The committee’s scrutiny has shaped regulatory trajectories at agencies including Health Canada and the Public Health Agency of Canada and influenced public debates covered by media outlets like the Canadian Broadcasting Corporation and the Globe and Mail.

History and Evolution

The committee evolved in response to historical public health challenges and legislative reforms in Ottawa, including responses to the 1918 influenza pandemic influence on federal health policy and later health system debates during the 1970s Canadian health care reforms. Its role expanded with the creation of bodies such as the Public Health Agency of Canada and the Canadian Institutes of Health Research in the early 2000s, and it played a prominent role during national crises including the 2003 SARS outbreak and the COVID-19 pandemic in Canada. Over successive Parliaments, membership, procedure and scope adapted to new statutes like the Cannabis Act, shifts in party composition in the House of Commons of Canada, and evolving priorities articulated by ministers such as the Minister of Health (Canada) and premiers across provinces.

Category:Committees of the House of Commons of Canada